# Effect of Paricalcitol Over Vessel Wall

> **NCT02372695** · PHASE4 · TERMINATED · sponsor: **Effice Servicios Para la Investigacion S.L.** · enrollment: 50 (actual)

## Conditions studied

- Nephropathy

## Interventions

- **DRUG:** Paricalcitol

## Key facts

- **NCT ID:** NCT02372695
- **Lead sponsor:** Effice Servicios Para la Investigacion S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-07
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** Protocol showed to be inappropriate for the evaluation of the selected patients
- **Last updated:** 2015-02-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02372695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02372695, "Effect of Paricalcitol Over Vessel Wall". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02372695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*